POST Online Media Lite Edition


Pfizer: Jeffrey B. Kindler retires, Ian C. Read successor

Staff writer |
New York, USA - December 6, 2010, New York, USA - Pfizer Inc. announced that it has elected Ian C. Read, currently head of the company's global biopharmaceutical operations, as president, chief executive officer and director.

Article continues below

Since 2006, Mr. Read has led Pfizer's Worldwide Biopharmaceutical Businesses which now comprises five global business units – Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Mr. Read joined Pfizer in 1978 and quickly assumed positions of increasing responsibility in Latin America.

In 1996, he was appointed President of Pfizer's International Pharmaceuticals Group, with responsibility for Latin America and Canada. He was named Corporate Vice President in 2001, and assumed responsibility for Europe in addition to Canada. Mr. Read later added the Africa/Middle East and Latin American regions to his leadership responsibility.


Ichnos Sciences appoints Sonia Quaratino to board
Ichnos Sciences welcomes Eric Feldman as new chief medical officer
Capital One Financial appoints Christine Detrick to board
Bankers Insurance hires David A. Erwin as president and CEO
American Equity Investment Life Holding appoints Dewayne Lummus as SVP

What to read next

Director M. Anthony Burns steps down from Pfizer
Intec Pharma appoints Jeffrey A. Meckler to board
Intec Pharma appoints Jeffrey A. Meckler as CEO